Additional Information
Book Details
Abstract
Clinical Naturopathy: In Practice applies the research, principles and treatment protocols outlined in Clinical Naturopathy: An Evidence-Based Guide to Practice, 2nd Edition.
Â
Written by a team of world-leading naturopathic practitioners and academics, Clinical Naturopathy: In Practice demonstrates the clinical decision-making processes in treating common conditions. It shares the clinical experiences of the expert authors, provides a gold-standard, integrative approach to real-world cases, and will guide you to deliver better clinical outcomes for your patients.
- Clinical pearls - key points to take into consideration during the examination process
- Diagnostic considerations
- Treatment protocols
- Example prescriptions
- Expected outcomes and Signposts for recovery - what to expect if treatment is effective or not
- Follow-up protocols - a guide of what to expect throughout the patient journey
- Clinical comprehension questions - to help understand practical concepts that drive the authors' clinical decision making
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | cover | ||
| Inside Front Cover | ifc1 | ||
| Clinical Naturopathy: In Practice | i | ||
| Copyright Page | iv | ||
| Dedications | v | ||
| Table Of Contents | vi | ||
| Editors | ix | ||
| Preface | x | ||
| Contributors | xii | ||
| Reviewers | xiv | ||
| Acknowledgments | xv | ||
| Evidence-based medicine and naturopathic practice | xvii | ||
| What is evidence-based medicine? | xviii | ||
| Evidence-based medicine in practice: key concepts | xviii | ||
| Individualised treatment | xviii | ||
| Clinical justification for treatments | xix | ||
| Proper procedures | xix | ||
| Patient-centred outcomes | xx | ||
| What about traditional evidence? | xxi | ||
| Limitations and problems in EBM | xxii | ||
| The perceived conflict between naturopathy and EBM—is it really reflective? | xxiii | ||
| Where is the evidence? | xxiv | ||
| Conclusion | xxiv | ||
| Acknowledgement | xxiv | ||
| References | xxv | ||
| 1 Gastrointestinal system | 1 | ||
| 1 Diarrhoea-predominant irritable bowel syndrome and anxiety | 2 | ||
| Diagnostic considerations | 2 | ||
| Treatment protocol | 3 | ||
| Expected outcomes and follow-up protocols | 4 | ||
| Bibliography | 5 | ||
| 2 Gastro-oesophageal reflux disease and functional constipation | 6 | ||
| Diagnostic considerations | 7 | ||
| Treatment protocol | 7 | ||
| Expected outcomes and follow-up protocols | 8 | ||
| Bibliography | 9 | ||
| 3 Food intolerance | 10 | ||
| Diagnostic considerations | 10 | ||
| Treatment protocol | 11 | ||
| Expected outcomes and follow-up protocols | 13 | ||
| Bibliography | 14 | ||
| 4 Gastritis | 15 | ||
| Diagnostic considerations | 15 | ||
| Treatment protocol | 16 | ||
| Expected outcomes and follow-up protocols | 17 | ||
| Bibliography | 19 | ||
| 5 Non-alcoholic fatty liver disease | 20 | ||
| Diagnostic considerations | 20 | ||
| Treatment protocol | 21 | ||
| Expected outcomes and follow-up protocols | 22 | ||
| Bibliography | 24 | ||
| 2 Respiratory system | 25 | ||
| 6 Acute upper respiratory tract infection | 26 | ||
| Diagnostic considerations | 26 | ||
| Treatment protocol | 27 | ||
| Expected outcomes and follow-up protocols | 29 | ||
| Bibliography | 30 | ||
| 7 Asthma | 31 | ||
| Diagnostic considerations | 31 | ||
| Treatment protocol | 31 | ||
| Expected outcomes and follow-up protocols | 33 | ||
| Bibliography | 34 | ||
| 8 Chronic sinusitis | 35 | ||
| Diagnostic considerations | 35 | ||
| Treatment protocol | 35 | ||
| Expected outcomes and follow-up protocols | 38 | ||
| Bibliography | 38 | ||
| 3 Cardiovascular system | 39 | ||
| 9 Cardiovascular disease and comorbid depression | 40 | ||
| Diagnostic considerations | 40 | ||
| Treatment protocol | 41 | ||
| Expected outcomes and follow-up protocols | 43 | ||
| Acknowledgement | 44 | ||
| Bibliography | 44 | ||
| 10 Hypertension | 45 | ||
| Diagnostic considerations | 45 | ||
| Treatment protocol | 46 | ||
| Expected outcomes and follow-up protocols | 47 | ||
| Acknowledgement | 49 | ||
| Bibliography | 49 | ||
| 11 Erectile dysfunction | 50 | ||
| Diagnostic considerations | 50 | ||
| Treatment protocol | 51 | ||
| Expected outcomes and follow-up protocols | 52 | ||
| Bibliography | 53 | ||
| 12 Chronic venous insufficiency | 54 | ||
| Diagnostic considerations | 54 | ||
| Treatment protocol | 55 | ||
| Expected outcomes and follow-up protocols | 56 | ||
| Bibliography | 57 | ||
| 4 Nervous system | 59 | ||
| 13 Bipolar disorder with comorbid ADHD | 60 | ||
| Diagnostic considerations | 60 | ||
| Treatment protocol | 61 | ||
| Expected outcomes and follow-up protocols | 62 | ||
| Bibliography | 63 | ||
| 14 Chronic anxiety with comorbid insomnia | 64 | ||
| Diagnostic considerations | 64 | ||
| Treatment protocol | 65 | ||
| Expected outcomes and follow-up protocols | 66 | ||
| Bibliography | 68 | ||
| 15 Clinical depression | 69 | ||
| Diagnostic considerations | 69 | ||
| Treatment protocol | 70 | ||
| Expected outcomes and follow-up protocols | 71 | ||
| Bibliography | 72 | ||
| 16 Migraine (nervous) | 73 | ||
| Diagnostic considerations | 73 | ||
| Treatment protocol | 74 | ||
| Expected outcomes and follow-up protocols | 75 | ||
| Bibliography | 76 | ||
| 17 Ageing and cognition | 77 | ||
| Diagnostic considerations | 77 | ||
| Treatment protocol | 78 | ||
| Expected outcomes and follow-up protocols | 79 | ||
| Bibliography | 80 | ||
| 18 Chronic fatigue syndrome | 81 | ||
| Diagnostic considerations | 81 | ||
| Treatment protocol | 82 | ||
| Expected outcomes and follow-up protocols | 84 | ||
| Bibliography | 85 | ||
| 5 Endocrine system | 87 | ||
| 19 Hypothyroidism | 88 | ||
| Diagnostic considerations | 88 | ||
| Treatment protocol | 90 | ||
| Expected outcomes and follow-up protocols | 93 | ||
| Bibliography | 94 | ||
| 20 Generalised stress and fatigue | 95 | ||
| Diagnostic considerations | 95 | ||
| Treatment protocol | 96 | ||
| Expected outcomes and follow-up protocols | 97 | ||
| Bibliography | 98 | ||
| 21 Metabolic syndrome | 99 | ||
| Diagnostic considerations | 99 | ||
| Treatment protocol | 100 | ||
| Expected outcomes and follow-up protocols | 102 | ||
| Bibliography | 104 | ||
| 6 Reproductive system | 105 | ||
| 22 Dysmenorrhoea | 106 | ||
| Diagnostic considerations | 106 | ||
| Treatment protocol | 107 | ||
| Expected outcomes and follow-up protocols | 108 | ||
| Bibliography | 109 | ||
| 23 Endometriosis and menorrhagia | 110 | ||
| Diagnostic considerations | 110 | ||
| Treatment protocol | 111 | ||
| Expected outcomes and follow-up protocols | 112 | ||
| Bibliography | 113 | ||
| 24 Fibroids | 114 | ||
| Diagnostic considerations | 114 | ||
| Treatment protocol | 115 | ||
| Expected outcomes and follow-up protocol | 116 | ||
| Bibliography | 117 | ||
| 25 Polycystic ovarian syndrome | 118 | ||
| Diagnostic considerations | 118 | ||
| Treatment protocol | 119 | ||
| Expected outcomes and follow-up protocols | 119 | ||
| Bibliography | 121 | ||
| 26 General menstrual complaints | 122 | ||
| Diagnostic considerations | 122 | ||
| Treatment protocol | 124 | ||
| Expected outcomes and follow-up protocols | 124 | ||
| Bibliography | 126 | ||
| 27 Perimenopausal patients | 127 | ||
| Diagnostic considerations | 127 | ||
| Treatment protocol | 128 | ||
| Expected outcomes and follow-up protocols | 129 | ||
| Bibliography | 130 | ||
| 28 Assisted reproduction (IVF) | 131 | ||
| Diagnostic considerations | 131 | ||
| Treatment protocol | 132 | ||
| Expected outcomes and follow-up protocols | 133 | ||
| Bibliography | 134 | ||
| 29 Subfertility | 135 | ||
| Diagnostic considerations | 135 | ||
| Treatment protocol | 136 | ||
| Expected outcomes and follow-up protocols | 137 | ||
| Bibliography | 138 | ||
| 7 Musculoskeletal system | 139 | ||
| 30 Osteoarthritis and myofascial pain syndrome | 140 | ||
| Diagnostic considerations | 140 | ||
| Treatment protocol | 141 | ||
| Expected outcomes and follow-up protocols | 142 | ||
| Bibliography | 143 | ||
| 31 Rheumatoid arthritis | 145 | ||
| Diagnostic considerations | 145 | ||
| Treatment protocol | 146 | ||
| Expected outcomes and follow-up protocols | 147 | ||
| Bibliography | 149 | ||
| 32 Fibromyalgia | 150 | ||
| Diagnostic considerations | 150 | ||
| Treatment protocol | 151 | ||
| Expected outcomes and follow-up protocols | 152 | ||
| Bibliography | 154 | ||
| 33 Tension and migraine headache | 155 | ||
| Diagnostic considerations | 155 | ||
| Treatment protocol | 157 | ||
| Expected outcomes and follow-up protocols | 158 | ||
| Bibliography | 159 | ||
| 8 Skin conditions | 161 | ||
| 34 Allergies and eczema | 162 | ||
| Diagnostic considerations | 162 | ||
| Treatment protocol | 163 | ||
| Expected outcomes and follow-up protocol | 164 | ||
| Bibliography | 165 | ||
| 35 Acne vulgaris | 166 | ||
| Diagnostic considerations | 166 | ||
| Treatment protocol | 167 | ||
| Expected outcomes and follow-up protocols | 168 | ||
| Bibliography | 169 | ||
| 36 Eczema and psoriasis | 170 | ||
| Diagnostic considerations | 170 | ||
| Treatment protocol | 171 | ||
| Expected outcomes and follow-up protocols | 172 | ||
| Bibliography | 173 | ||
| 37 Hormonal acne | 174 | ||
| Diagnostic considerations | 174 | ||
| Treatment protocol | 175 | ||
| Expected outcomes and follow-up protocol | 177 | ||
| Bibliography | 177 | ||
| 9 Urinary system | 179 | ||
| 38 Benign prostatic hypertrophy and erectile dysfunction | 180 | ||
| Diagnostic considerations | 180 | ||
| Treatment protocol | 181 | ||
| Expected outcomes and follow-up protocols | 182 | ||
| Bibliography | 183 | ||
| 39 Recurrent urinary tract infections | 184 | ||
| Diagnostic considerations | 184 | ||
| Treatment protocol | 185 | ||
| Expected outcomes and follow-up protocols | 187 | ||
| Bibliography | 188 | ||
| 10 Cancer | 189 | ||
| 40 Bowel cancer | 190 | ||
| Diagnostic considerations | 190 | ||
| Treatment protocol | 191 | ||
| Expected outcomes and follow-up protocols | 193 | ||
| Bibliography | 193 | ||
| 41 Prostate cancer | 195 | ||
| Diagnostic considerations | 195 | ||
| Treatment protocol | 196 | ||
| Expected outcomes and follow-up protocols | 198 | ||
| Bibliography | 199 | ||
| 11 Paediatrics | 201 | ||
| 42 Paediatric immune dysregulation | 202 | ||
| Diagnostic considerations | 202 | ||
| Treatment protocol | 203 | ||
| Expected outcomes and follow-up protocols | 205 | ||
| Bibliography | 206 | ||
| 43 Nocturnal enuresis | 207 | ||
| Diagnostic considerations | 207 | ||
| Treatment protocol | 208 | ||
| Expected outcomes and follow-up protocols | 209 | ||
| Bibliography | 210 | ||
| 12 Infectious diseases | 211 | ||
| 44 HIV | 212 | ||
| Diagnostic considerations | 212 | ||
| Treatment protocol | 213 | ||
| Expected outcomes and follow-up protocols | 214 | ||
| Bibliography | 216 | ||
| 13 Complex conditions | 217 | ||
| 45 Malvaria (pyroluria) | 218 | ||
| Diagnostic considerations | 218 | ||
| Treatment protocol | 219 | ||
| Expected outcomes and follow-up protocols | 221 | ||
| Bibliography | 222 | ||
| 46 Pain management | 223 | ||
| Diagnostic considerations | 223 | ||
| Treatment protocol | 224 | ||
| Expected outcomes and follow-up protocols | 226 | ||
| Bibliography | 226 | ||
| 47 Polypharmacy patients | 227 | ||
| Diagnostic considerations | 227 | ||
| Treatment protocol | 228 | ||
| Expected outcomes and follow-up protocols | 230 | ||
| Bibliography | 231 | ||
| Index | 232 | ||
| A | 232 | ||
| B | 233 | ||
| C | 233 | ||
| D | 235 | ||
| E | 235 | ||
| F | 236 | ||
| G | 237 | ||
| H | 238 | ||
| I | 239 | ||
| K | 239 | ||
| L | 239 | ||
| M | 240 | ||
| N | 241 | ||
| O | 241 | ||
| P | 242 | ||
| Q | 243 | ||
| R | 243 | ||
| S | 244 | ||
| T | 244 | ||
| U | 245 | ||
| V | 245 | ||
| W | 245 | ||
| Y | 245 | ||
| Z | 245 |